Cite
Cardoso JMO, Brito RCF, Mathias FAS, et al. Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis. Mol Immunol. 2021;141:70-78doi: 10.1016/j.molimm.2021.11.011.
Cardoso, J. M. O., Brito, R. C. F., Mathias, F. A. S., Reis, L. E. S., Vieira, J. F. P., Ostolin, T. L. V. D. P., Andrade, H. M., Ramos, G. S., Frézard, F., Aguiar-Soares, R. D. O., Roatt, B. M., & Reis, A. B. (2021). Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis. Molecular immunology, 14170-78. https://doi.org/10.1016/j.molimm.2021.11.011
Cardoso, Jamille Mirelle de Oliveira, et al. "Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis." Molecular immunology vol. 141 (2021): 70-78. doi: https://doi.org/10.1016/j.molimm.2021.11.011
Cardoso JMO, Brito RCF, Mathias FAS, Reis LES, Vieira JFP, Ostolin TLVDP, Andrade HM, Ramos GS, Frézard F, Aguiar-Soares RDO, Roatt BM, Reis AB. Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis. Mol Immunol. 2021 Nov 20;141:70-78. doi: 10.1016/j.molimm.2021.11.011. Epub 2021 Nov 20. PMID: 34814056.
Copy
Download .nbib